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Synthetic ionophores as non-resistant antibiotic
adjuvants†
Mohit B. Patel, *b Evan Garrad,b Joseph W. Meisel,
Michael R. Gokela and George W. Gokel *b

a

Saeedeh Negin,

a

Antimicrobial resistance is a world-wide health care crisis. New antimicrobials must both exhibit potency
and thwart the ability of bacteria to develop resistance to them. We report the use of synthetic
ionophores as a new approach to developing non-resistant antimicrobials and adjuvants. Most studies
involving amphiphilic antimicrobials have focused on either developing synthetic amphiphiles that show
ion transport, or developing non-cytotoxic analogs of such peptidic amphiphiles as colistin. We have
rationally designed, prepared, and evaluated crown ether-based synthetic ionophores (‘hydraphiles’) that
show selective ion transport through bilayer membranes and are toxic to bacteria. We report here that
hydraphiles exhibit a broad range of antimicrobial properties and that they function as adjuvants in
concert with FDA-approved antibiotics against multi-drug resistant (MDR) bacteria. Studies described
herein demonstrate that benzyl C14 hydraphile (BC14H) shows high eﬃcacy as an antimicrobial. BC14H, at
sub-MIC concentrations, forms aggregates of 200 nm that interact with the surface of bacteria.
Surface-active BC14H then localizes in the bacterial membranes, which increases their permeability. As
a result, antibiotic inﬂux into the bacterial cytosol increases in the presence of BCnHs. Eﬄux pump
inhibition and accumulation of substrate was also observed, likely due to disruption of the cation
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gradient. As a result, BC14H recovers the activity of norﬂoxacin by 128-fold against resistant

DOI: 10.1039/c8ra07641c

Staphylococcus aureus. BC14H shows extremely low resistance development and is less cytotoxic than
colistin. Overall, synthetic ionophores represent a new scaﬀold for developing eﬃcient and non-resistant
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antimicrobial-adjuvants.

Introduction
The worldwide crisis in bacterial resistance to antibiotics,
documented by recent CDC and WHO reports, needs little
introduction.1 The problems of antibiotic over-prescription and
incomplete regimens are exacerbated by the meager antimicrobial pipeline.1 At present, there is resistance to every FDAapproved antibiotic. The need for new approaches can hardly
be overstated.
Two new discovery approaches have recently been reported
as a means to obtain antimicrobial peptides from soil microbes.
Teixobactin was identied using an iChip that allows culture of
previously unculturable bacteria.2 Malacidins were identied
using culture-independent studies of DNA samples from soil
microbes.3 Notwithstanding these new antibiotics were identied as non-resistant by sequential culturing methods,2,3 gene
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transfer from the bacteria producing them could eventually lead
to resistance. Such discovery methods are critical to address the
antibiotic-resistance crisis, but diﬀer fundamentally from the
approach presented here.
We have designed and synthesized amphiphiles called
hydraphiles that form cation-selective channels in membranes.
Some of these compounds exhibit signicant antimicrobial
properties attributed to the disruption of ion gradients in
bacteria.4 Numerous synthetic amphiphiles have been reported,
but studies of them were generally limited either to ion transport5 or to a simple survey of antimicrobial potency.6 We report
here that hydraphiles form cation selective channels in
membranes and recover antimicrobial potency against multidrug resistant (MDR) bacteria by increasing the cytosolic
concentration of antibiotics within the pathogen.
Poor membrane permeability and eﬄux pump function have
long been recognized as important contributors to bacterial
resistance.7 Eﬄux pump proteins require a cation gradient or
ATP hydrolysis to drive xenobiotics from the bacterial cytosol.8,9
Disruption of these gradients oﬀers a potential mechanism by
which resistance may be diminished or eliminated. Antimicrobial resistance in Gram-negative bacteria is typically
a combination of second membrane-diminished inux and
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increased antibiotic eﬄux.10 Membrane active molecules, such
as colistin11 and daptomycin,11 disrupt bacterial membranes
and permit increased antimicrobial inux. Sadly, resistance
even to these potent antibiotics has recently emerged.12
However, to our knowledge, there is no report of any synthetic
adjuvant that can inhibit eﬄux pump activity and increase
membrane permeability to antibiotics. The use of synthetic ion
channels as antimicrobial adjuvants not only comprises a new
approach, but it also impedes resistance development, as these
synthetic amphiphiles are not produced by bacteria.
We report here the application of synthetic amphiphiles
(hydraphiles) that penetrate membranes and form cation
selective channels. Hydraphiles form aggregates of 200 nm
that attach to the surface of bacteria. The surface-attached
hydraphiles then localize in the Escherichia coli membranes,
transport potassium (K+) ions, and selectively increase
membrane permeability. The disruption of cation gradients/
transport caused by hydraphiles inhibits eﬄux pump activity,
whereas increased membrane permeability allows for higher
antibiotic inux. As a result the antibiotic concentration in the
cytoplasm of MDR bacteria increases, and its activity is recovered. The amphiphile we call benzyl C14 hydraphile (BC14H, 4) is
our most potent adjuvant: it rescues the antibiotic potency in
resistant E. coli, MDR Klebsiella pneumoniae, and Staphylococcus
aureus. E. coli failed to develop resistance to BC14H over 15 days.
BC14H also shows generally lower mammalian cytotoxicity than
does colistin.

Experimental section
Compounds used
Synthetic amphiphiles and antibiotics were used for the studies
reported here. Synthetic amphiphiles used are called hydraphiles. Hydraphiles were synthesized in the Gokel lab and
purity was conrmed by NMR and mass spectrometry. Four
hydraphiles diﬀering in its spacer chain lengths were used. We
used benzyl C8, C10, C12 and C14 hydraphile. The antibiotics of
choice were tetracycline, ampicillin, ciprooxacin, and colistin.
CCCP and reserpine, known eﬄux pump inhibitors were also
used as controls. Gramicidin-D, valinomycin and Triton X-100
were used as ion transport and detergent controls. All the
antibiotics, known EPIs and controls were received from SigmaAldrich and used as received. Hydraphiles, gramicidin-D, and
valinomycin were dissolved in DMSO. All the other compounds
were dissolved in autoclaved milli-Q H2O.

Hydraphile syntheses
Compounds 1, 2, 3, and 4 are analogs that diﬀer only in the
lengths of the polymethylene units connecting the two distal
macrocycles to the central ring. Detailed syntheses are reported
in N. S. Curvey, S. E. Luderer, J. K. Walker, and G. W. Gokel,
Improved Syntheses of Benzyl Hydraphile Synthetic CationConducting Channels, Synthesis, 2014, 46, 2771–2779.
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Bacteria used
There were 27 strains of bacteria used for this study. Most of the
strains listed in Tables 1 and S1† were cultured in cation
adjusted Mueller Hinton II (MHII) media. The S. pneumoniae
was cultured in CA-MHB with 5% LHB media. tetR E. coli was
prepared by transforming the competent JM109 E. coli with
pBR322 plasmid (Carolina Biological). The transformation was
performed using heat-shock method as outlined by the manufacturer (Promega). The resulting E. coli cells were tetracycline
and ampicillin resistant and designated tetR E. coli. The tetR E.
coli expressed tetA eﬄux pump and b-lactamase enzyme. tetR E.
coli was always used in LB media with 100 mg mL1 ampicillin.
The Klebsiella pneumoniae (ATCC BAA 2146™) strain was
acquired from ATCC. It is a clinical relevant strain (BSL-2) that
was reported to be isolated from a patient's urine sample. The K.
pneumoniae is reported to be resistant to more than 30 diﬀerent
antibiotics including classes such as carbapenems, uoroquinolones, cephalosporins, macrolides and tetracyclines. It
expresses eﬄux pumps from three diﬀerent classes: RND, ABC
and MFS. TetA is the MFS type eﬄux pump expressed in the K.
pneumoniae, which is used for the combination study. The K.
pneumoniae strain was used in the MHII media. S. aureus
1199B13 was a gi Dr Glenn Kaatz, it was cultured in MHII
media as well.

Minimal inhibitory concentration (MIC)
tetR E. coli was grown in LB Miller media containing 100 mg
mL1 ampicillin. K. pneumoniae was grown in the cation
adjusted MHII media. The cells were grown overnight from one
colony forming unit (CFU) in 2 mL media. On the day of the
experiment, bacteria were knocked back to OD600 ¼ 0.100 and
incubated at 37  C until the OD600 reached 0.500 (4  108 CFU
mL1). The cell density was adjusted to 4  106 CFU mL1. The
20 mL diluted cells were added to each well (nal volume/well ¼
200 mL) aer the addition of antibiotics or synthetic amphiphiles. The nal cell concentration per well was 4  105 CFU
mL1.
In a 96-well plate, rst the media was added followed by
addition of the compounds. The nal volume of each well was
200 mL. Compounds were either dissolved in DMSO or dH2O.
Compounds were always administered at a constant volume
such that the nal DMSO concentration in each well was 0.5%
volume/volume (1 mL of nal 200 mL). For combination studies,
aer the addition of amphiphiles, antibiotics were added. The
compounds or antibiotics that were dissolved in dH2O, 10 mL
per well was used. In the case of DMSO alone control, 1 mL of
DMSO was added to each well. For dH2O control, 10 mL of dH2O
was added to each well. No compound or solvent was added for
cells alone and media alone control. Contents of the well were
thoroughly mixed by pipetting up and down three times. Aer
mixing, 20 mL cells were added to each well. The plates were
incubated at 37  C for 18-20 hours. Results were collected by
determining the OD at l ¼ 600 nm using a plate reader (BioTek
Cytation 3). Each compound was tested in triplicate per plate.
Percent inhibition was calculated by comparing to the cell alone
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MIC screening of hydraphiles and antibiotics

Strain ID

Antibiotic used

[Antibiotic]
(mM)

[Comp. 2]
(mM)

[Comp. 4]
(mM)

S. aureus (control)
MRSA (USA100)
MRSA (USA 300)
MRSA (control)
E. faecalis (control)
E. faecalis (VanA)
E. faecalis (VanB)
S. pneumoniae (control)
S. pneumoniae (R:Pen)
S. pneumoniae (R:Levo)
K. pneumoniae (ESBL, SHV-12)
K. pneumoniae (ESBL, FQR)
K. pneumoniae (KPC-2)
A. baumannii (FQR)
A. baumannii (R:Mero)
A. baumannii (WT)
P. aeruginosa (control)
P. aeruginosa (FQR)
P. aeruginosa (R:Mero)
E. cloacae (FQR)
E. cloacae (R:Mero)
E. aerogenes (R:Cep)
E. coli (WT)
E. coli (Tol-)

Vancomycin
Vancomycin
Vancomycin
Vancomycin
Daptomycin
Daptomycin
Daptomycin
Vancomycin
Vancomycin
Vancomycin
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem
Meropenem

0.5
1
1
1
2.5
2.5
0.62
<0.1
0.2
0.2
0.65
0.65
83
83
2.6
1.3
1.3
2.6
>166
1.3
42
<0.33
<0.33
<0.33

6
6
6
6
6
6
6
6
6
6
51
26
51
6.4
26
13
>100
>100
100
26
26
26
13
13

1.5
1.5
1.5
1.5
1.5
1.5
1.5
6
3
6
24
12
24
3
12
6
94
94
47
24
12
12
3
3

control. Growth inhibited of $90% was considered as the MIC.
The data was reproduced 2 more times on two separate plates.
Checkerboard
In a checkerboard experiment, each column of the plate had
diﬀerent concentration of the amphiphile increasing by serial
dilution. Two amphiphiles were tested per plate. Each row of
the checkerboard experiment had diﬀerent concentrations of
antibiotics increasing by serial dilutions. The concentrations of
amphiphile and antibiotic tested were 1/2, 1/4, 1/8, 1/16 and 1/
32 the MIC. E. coli and K. pneumoniae were tested using the
checkerboard experiment. The MIC procedure used for the
checkerboard experiment was the same as outlined above. Cells
and compound alone controls were also used. The checkerboard experiment did not have a biological replicate but the
data was reproduced three times before reporting. The data was
represented as a heat map.
Growth curve
The growth curve experiment was performed using tetR E. coli.
The compounds studied using growth curves were benzyl C14
hydraphile and tetracycline. Here, the E. coli was grown overnight from one CFU in LB Miller media containing 100 mg mL1
ampicillin. On the day of the experiment the cells were knocked
back in LB Miller media containing 100 mg mL1 ampicillin, to
OD600 ¼ 0.550 before use. In a sterile 250 mL ask, 50 mL LB
media was added, followed by benzyl C14 hydraphile and
tetracycline. The concentrations of benzyl C14 hydraphile tested
were 1 and 2 mM. The concentrations of tetracycline tested were
220 and 900 mM. In addition, a growth curve containing
This journal is © The Royal Society of Chemistry 2019

a combination of benzyl C14 hydraphile (1 mM) and tetracycline
(220 mM) was also tested. Cells only and DMSO (0.5% v/v) alone
controls were also performed. Compounds were mixed by
swirling the ask. To each ask, knocked back cells were added
so that the nal cell concentration in each ask was approximately 4  105 CFU mL1. The asks were incubated at 37  C
and 200 RPM. A 2 mL sample was taken every 30 minutes (for
next 24 hours) to determine the OD at l ¼ 600 nm. A graph was
plotted for OD vs. time to generate a growth curve. Average of
three trials was used to determine the optical density. Standard
deviation in the results was used to plot the error bars.
Localization in bacterial cells
tetR E. coli was grown overnight from one CFU in LB miller
media containing 100 mg mL1 ampicillin. E. coli was knocked
back and grown to OD (600 nm) ¼ 1.300 before use. Cells were
centrifuged at 6500 RM (3000  g) for 5 minutes and resuspended in PBS. Dansyl labeled C14 dansyl hydraphile (Cf ¼ 2
mM) was added to 1990 mL of cells. For co-localization study,
FM4-64 FX (Cf ¼ 10 mg mL1) were also added. The cells were
incubated for 5 minutes at 200 RPM and 37  C. Cells were
washed again at 6500 RPM (3000  g) for 5 minutes and resuspend the cells in fresh PBS. A 20 mL sample was loaded on
to clean glass slide and covered with coverslip. The slide was
observed using Zeiss LSM 700 microscope.
E. coli membrane permeability using PI and FDA
To test the membrane permeability of the tetR E. coli, the
bacteria was rst grown overnight from one CFU in media
containing 100 mg mL1 ampicillin at 37  C and 200RPM. tetR E.
RSC Adv., 2019, 9, 2217–2230 | 2219
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coli was then knocked back to OD (600 nm) ¼ 0.550 before use.
In a sterile test tube, cells were added followed by either Triton
X-100, DMSO or compounds 1–4 at half-MIC concentrations
and incubated at 37  C and 200 RPM. The concentration of
DMSO was kept constant at 0.5% by volume in each case. Aer
30 minutes of incubation, the cells were washed by centrifugation at 3000  g for 5 minutes and re-suspended in sterile
phosphate buﬀered saline (PBS). Propidium iodide (30 mM,
Thermo-Fischer) and uorescein diacetate (60 mM, SigmaAldrich) were added to the tetR E. coli cells in the PBS, mixed
by vortexing and incubated at 37  C and 200 RPM. Aer 30
minutes, the cells were washed again by centrifugation at 3000
 g for 5 minutes. The pellet was suspended in a fresh PBS,
loaded onto a clean glass slide, covered with a cover slip and
observed under Zeiss LSM 700 confocal microscope.
Localization and permeability of HEK-293 cells
HEK-293 cells were donated by Dr Michael Nichols. Cell lines
were regularly maintained in growth media containing DMEM
(ATCC), 10% fetal bovine serum (FBS, ATCC) and 1% penicillin–
streptomycin solution (ATCC). Adherent HEK-293 cells were
trypsinized using 0.25% (w/v) trypsin–EDTA (Sigma-Aldrich),
suspended in a fresh media and diluted to get a concentration of 3  105 cells per mL. Cells were seeded in a 96-well plate
(100 mL per well) to get 3  104 cells per well. The plates were
incubated for 24 hours at 5% CO2 and 37  C to reach a conuency of 80–90%.
In a sterile 1.5 mL micro-centrifuge tube, dansyl C14 hydraphile and dansyl C16 lariat ether (0.5% DMSO) were mixed with
PBS. FM4-64 FX, DAPI and PI were also added to PBS for colocalization study. The spent media in the plate was replaced
with 100 mL media containing dansyl labeled amphiphiles and
other stains. The cells were incubated at 37  C and 5% CO2 for
30 minutes before observing under Zeiss LSM 700.
For permeability study, the cells were cultured as outlined
above. HEK-293 (90% conuent) were then seeded in a 96-well
plate to get 30 000 cells per well. Aer 24 hours of incubation at
37  C and 5% CO2, the spent media was replaced with media
(DMEM and 10% FBS) containing compound 1–4 at 1/2 or 2
MIC. Triton X-100 at 0.1%-by volume (1670 mM) and DMSO
0.5% by volume were also used as controls. Aer 2 hours of
incubation, spent media was replaced with PBS containing
propidium iodide (30 mM) and uorescein diacetate (60 mM) and
incubated at 37  C and 5% CO2. Aer 2 hour of incubation, the
spend media was replaced with fresh PBS and the cells were
observed under Zeiss LSM 700 confocal microscope. The images
were reported without any alterations. The gain and the intensity in all the images were kept constant.
Scanning electron microscopy
To perform scanning electron microscopy tetR E. coli was grown
overnight from one CFU in LB miller media containing 100 mg
mL1 ampicillin. E. coli was knocked back and grown to OD (600
nm) ¼ 1.000 before use. For E. coli alone control, the lter
membrane (0.45 mm) was dipped in the E. coli culture. E. coli
was treated with various concentration of C8 and C14

2220 | RSC Adv., 2019, 9, 2217–2230

Paper

hydraphiles for 10 minutes before loading on to lter
membrane. The cells were xed by transferring the lter
membrane containing E. coli cells to 2.5% (v/v) glutaraldehyde
(stock 25%) for 60 min. Cells were washed for 15 minutes by
transferring the membrane in PBS. The cells were stained by
transferring the membrane to 1% (v/v) OsO4 for 1 hour. Serial
dehydration of the sample was performed with 30%, 50%, 70%,
80%, 90%, 100%, 100% (v/v) ethanol. Sample was dipped in
each ethanol concentration for 10 minutes. The cells were
critical-point dried and sputter coated with gold before
observing under JOEL 6320F SEM. The images were acquired
and reports without any modications.
Potassium transport
The experiment was conducted with tetR E. coli. E. coli was
grown overnight from one CFU. Cells were knocked back to OD
¼ 0.600 before use. Cells were centrifuged at 2000  g and
resuspended in sterile PBS. The OD of cells was adjusted to
1.300. To measure the K+ leakage, 1998 mL E. coli suspended in
PBS were added to a plastic cup containing magnetic stirrer.
The stir plate was turned on to mix the sample and the potassium selective electrode (Orion, Thermo Scientic) was
immersed in the sample so that just the membrane was covered
in the sample. The voltage (mV) was stabilized for 6–8 minutes.
The temperature of the sample was kept constant at 25  C. The
electrode was lied and 2 mL of the either of the hydraphiles or
gramicidin-D were added. The DMSO concentration was kept
constant at 0.1% (v/v). The electrode was immersed back in the
solution. Multiple concentrations were tested for each
compound. The mV reading was recorded every 30 seconds for
15 minutes. The concentration of potassium ion released (mM)
and D[K+] mM were calculated using the equation from the
calibration curve.
To determine the total potassium pool of tetR E. coli, 2 mL of
cells were heated at 100  C for 30 minutes on a heat block. Aer
30 minutes the sample was cooled down to room temperature
for 60 minutes. Aer 60 minutes the mV reading was recorded
and D[K+] mM was calculated. The experiment was performed
in triplicates and standard deviation in the experiment was
calculated.
Eﬄux pump inhibition
Eﬄux pump inhibition studies were conducted with S. aureus
1199B in a 96-well microtiter plate with black wells and glass
bottom. S. aureus 1199B were grown overnight from one CFU.
Cells were knocked back to OD600 ¼ 0.550 before use. In
a 1.5 mL micro-centrifuge tube, cell were spun down at 17 000 
g for 3 minutes. Cell were re-suspended in fresh MHII media
containing 10 mg mL1 ethidium bromide and 100 mM CCCP.
The OD600 was adjusted to 1.000. The cells were vortexed and
incubated at the room temperature for 20 minutes to load cells
with ethidium bromide. Aer 20 minutes, the cells were
centrifuged at 17 000  g for 3 minutes. The supernatant was
discarded and the cells were stored on ice. The tubes were
warmed to room temperature for 5 minutes and MHII media
was added to the tubes and OD600 was adjusted to 0.800. 100 mL

This journal is © The Royal Society of Chemistry 2019
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of ethidium bromide loaded cells were added to each well
containing either C8–C14 hydraphiles, CCCP or reserpine. The
contents were mixed by pipetting up and down once and the
uorescence was recorded immediately using Biotek Cytation 3
plate reader. Excitation of 530 nm and emission of 600 nm was
used. Reading were collected every minute for 20 minutes. The
results were reproduced two more times and standard deviation
was calculated. The results were graphed against time.
Ethidium bromide accumulation
Eﬄux pump inhibition studies were conducted with S. aureus
1199B in a 96-well microtiter plate with black wells and glass
bottom. S. aureus 1199B were grown overnight from one CFU.
Cells were knocked back to OD600 ¼ 0.550 before use. While the
cells grew to the optimal conditions, hydraphiles, CCCP and
reserpine stock concentrations were prepared. Mid-log phase
cells were centrifuged at 17 000  g for 3 minutes and resuspended in fresh MHII media. The OD600 was adjusted to
0.800. In each well 200 mL of cells were added followed by 10 mg
mL1 of ethidium bromide and 1 mL of C8–C14 hydraphiles,
reserpine or CCCP. The contents of the well were mixed by
pipetting up and down once. Immediately uorescence was
measured using the Biotek Cytation 3 plate reader. Excitation of
530 nm and emission of 600 nm was used. Reading were
collected every minute for 20 minutes. The results were reproduced two more times and standard deviation was calculated.
The results were graphed against time.
Resistance development to hydraphiles
The ability of tetR E. coli to develop resistance to benzyl C14
hydraphiles and minocycline was determined using sequential
culturing method. This method tests the ability of bacteria to
develop resistance by inducing constant selective pressure of
sub-lethal dose of antibiotics over 15 days. This procedure also
accounts for only point mutations. The tetR E. coli was grown
overnight from one colony in LB media. E. coli was knocked
back to OD 600 nm ¼ 0.100 in a 2 mL LB media and grown to
OD ¼ 0.550. LB media was added to the test tubes, followed by
the antibiotic and then the E. coli and incubated at 37  C, 200
RPM for 24 hours. Five diﬀerent concentrations of hydraphiles
and minocycline were set up: 0.25, 0.5, 1, 2, and 4 MIC.
Any cultures that grew at higher than the MIC levels were
passaged on antibiotic-free LB Agar plates and the MIC is
determined. The samples were also stored for future use. The
cells were diluted from the second highest concentration that
allowed growth at 1 : 100 in fresh media containing 0.25, 0.5, 1,
2, 2.5 and 4 MIC. Test tubes were incubated at 37  C, 200 RPM
for 24 hours. Any cultures that grew at higher than the MIC
levels were passaged on antibiotic-free LB Agar plates and the
MIC was determined. The procedure was continued for 15 days.
The results are represented in graphical format of MIC vs. days.
Average from three trials was used to plot MIC on the graph.
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and HEK-293 cells were donated by Dr Michael Nichols. Cell
lines were regularly maintained in growth media containing
DMEM (ATCC), 10% fetal bovine serum (FBS, ATCC) and 1%
penicillin-streptomycin solution (ATCC). Adherent HEK-293,
HeLa and Cos-7 cells were trypsinized using 0.25% (w/v)
trypsin–EDTA (Sigma-Aldrich), suspended in a fresh media
and diluted to get a concentration of 3  105 cells per ml. Cells
were seeded in a 96-well plate (100 mL per well) to get 3  104
cells per well. The plates were incubated for 24 hours at 5% CO2
and 37  C to reach a conuency of 80–90%.
In a sterile 1.5 mL micro-centrifuge tube, benzyl C8–C14
hydraphile, CCCP and colistin (0.5% DMSO) were mixed with
assay media (DMEM + 10% FBS) and serially diluted by 2-fold
each to get MIC, 1/2 MIC and 1/4 MIC concentrations. A control
containing 0.5% DMSO was also prepared. Aer 24 hours, the
spent media in the 96-well plate containing HEK-293, HeLa and
Cos-7 cells (90% conuency) was replaced with 100 mL media
containing the benzyl C8–C14 hydraphile, CCCP and colistin at
various concentrations. The cells were incubated at 37  C and
5% CO2 for 24 hours before performing XTT assay (SigmaAldrich). The XTT assay was performed according to the
manufacturer's protocol. Aer 24 hours of treatment with
compounds, the media was replaced with PBS and 25 mL XTT
was added to each well. The XTT assay works by the reduction of
tetrazolium compound by alive cells to the colored soluble
formazan product. The absorbance of the product was
measured at 450 nm (XTT) and 690 nm (background). Percent
survival was calculated by comparing the average absorbance of
cells treated with benzyl C8–C14 hydraphile, CCCP and colistin
to that of cells alone. Three replicates were performed for each
treatment. Average percent survival and standard deviation
were calculated and plotted on a graph.

Results and discussion
General
Crown ethers14 form complexes with metallic and organic
cations and transport them across various types of
membranes.15 Hydraphiles were designed to use crown ethers
as a module in a membrane-spanning scaﬀold to mimic protein
channel functions.16 Examples of these synthetic, cationconducting amphiphiles are illustrated in Fig. 1. Hydraphiles
typically possess three diaza-macrocycles connected by alkyl
spacer chains and may be represented schematically as
RhcrowniCnhcrowniCnhcrowniR. Herein, the crowns are 4,13diaza-18-crown-6 (hN18Ni) and the connectors (Cn) are polymethylene chains ranging in length from hexylene (C6) to

Mammalian cell cytotoxicity
HeLa (ATCC CCL-2) cells were acquired from ATCC. Cos-7
(ATCC CRL-1651) cells were donated by Dr Cynthia Dupureur

This journal is © The Royal Society of Chemistry 2019

Fig. 1

Structures of hydraphiles studied.

RSC Adv., 2019, 9, 2217–2230 | 2221

View Article Online

Open Access Article. Published on 17 January 2019. Downloaded on 4/3/2019 8:54:19 PM.
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

RSC Advances

eicosylene (C20).17 The channels that most eﬀectively conduct
alkali metal cations14 have Cn chains of 12–16 methylenes.18,19
These bilayer-spanning amphiphiles transport Na+ ions
through liposomes16 and exhibit antibacterial properties.4 We
previously reported that BC14H, when co-administered at sublethal concentrations, enhances the eﬃcacy of erythromycin,
kanamycin, rifampicin, and tetracycline against drug-sensitive
E. coli, Pseudomonas aeruginosa, and Bacillus subtilis.20,21 Based
on the membrane activity of hydraphiles, we initially postulated
that eﬃcacy resulted only from a permeability enhancement
mechanism. We now report evidence supporting the hypothesis
that hydraphiles also inhibit eﬄux pump function by disrupting
bacterial cation gradients.
Hydraphiles 1–4 have N-benzyl groups (R) on the distal
macrocycles and linear C8, C10, C12, or C14 spacer chains
(Fig. 1).22 Both ion transport and the antimicrobial activity of
hydraphiles depend on the overall length of the hydraphiles.4
We expected benzyl C8 and C10 hydraphiles to be controls as
they have shown poor ion transport through liposomes.14 The
antibiotics studied were tetracycline (5), ciprooxacin (6), and
noroxacin (7). The membrane disrupter colistin (8), the poreformer gramicidin-D (9),23 the carrier valinomycin (10),24 and
the detergent Triton X-100 (11)25 served as controls. Known
eﬄux pump inhibitors such as reserpine (12),21 and carbonyl
cyanide 3-chlorophenylhydrazone (CCCP, 13)26 were also used
as controls. Structures of controls and other hydraphiles are
shown in Fig. S1.†

Minimal inhibitory concentration studies
We determined the MICs of benzyl C10 and benzyl C14 hydraphiles (compounds 2 and 4) as well as those for known antibiotic controls (vancomycin, daptomycin, and meropenem)
against 24 bacterial strains. MICs were determined against
sensitive and resistant strains of methicillin resistant S. aureus
(MRSA), K. pneumoniae, E. coli, Enterococcus faecalis, Streptococcus pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter cloacae, and Enterobacter aerogenes (Table
1). Compound 4 was generally a more potent antimicrobial than
2. This activity correlates with the ability of BC14H (and not
BC10H) to span the membrane and to form ion-conducting
pores.
It was observed that BC14H was more eﬃcient than current
treatment options against highly problematic VRE and MRSA
(Gram-positive) strains. The MIC of daptomycin was 2.5 mM
against E. faecalis (VanA). The VanA and VanB clusters are
responsible for vancomycin resistance in one in three hospital
acquired enterococcal infections.1 The MIC for 4 against E.
faecalis (VRE/VanA) and MRSA (USA 100, 300) was 1.5 mM. The
MIC of vancomycin against MRSA was 1–2 mM. Strains of
vancomycin-resistant S. aureus have already been reported and
USA 300 and USA 100 are the most common community-and
hospital-associated strains. Based on the available treatment
options and existing resistance development, BC14H could be
considered for antimicrobial monotherapy against E. faecalis.
Synthetic amphiphiles typically show greater antimicrobial
activity towards Gram-positive than Gram-negative bacteria.27
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Even though the MICs of hydraphiles were higher (less potent)
against Gram-negative than Gram-positive bacteria, hydraphiles
were more active than controls against A. baumannii (FQR), K.
pneumoniae (FQR), and E. cloacae (R:Mero). For example, BC14H
was 28-fold, 3-fold and 2-fold more active, respectively, than
meropenem against A. baumannii (FQR), K. pneumoniae (KPC2),
and E. cloacae (meropenem resistant). The MIC of compound 4
ranged from 3–24 mM against these strains. The CDC has listed
these bacteria as serious and urgent threats.1 Table 1 shows the
results of screening for minimum inhibitory concentrations
(MICs) against a variety of microbes.

Adjuvant studies
An urgent need lies with carbapenem resistant Enterobacteriaceae (CRE) and MRSA. It is known that combinations of
antibiotics have a lower rate of resistance development than do
individual antimicrobials. Our goal is to use hydraphiles as
adjuvants to rescue the potency of antimicrobials against
bacteria such as CRE and MRSA that are an urgent public health
threat.
Typical approaches used to overcome resistance involve
either inhibition of the b-lactamase enzyme or a combination of
two (or more) diﬀerent antibiotics. Even though eﬄux pumps
are a major resistance mechanism, at present no eﬄux pump
inhibitor is available for therapeutic use. Hydraphiles 1–4 were
assessed for antimicrobial and adjuvant properties against
eﬄux pump expressing MDR bacteria.
The bacteria used for these studies were K. pneumoniae and
E. coli (Gram-negative), and S. aureus (Gram-positive). The K.
pneumoniae (ATCC BAA 2146™) strain was acquired from ATCC
and reported to be isolated from a patient's urine sample. It
expresses multiple diﬀerent eﬄux pumps (e.g. RND, ABC,
TetA).28 This strain is resistant to more than 25 diﬀerent antibiotics and served in these studies as a clinically relevant
control. The tetracycline resistant strain of E. coli (tetR E. coli)
was developed by transforming E. coli with the pBR322 plasmid,
which contains the tetA and AmpR genes.29 The tetA gene
expresses the TetA eﬄux pump and AmpR gene expresses the blactamase enzyme. The TetA eﬄux pump depends on proton
exchange for the transport of tetracycline.8 Since most of the
virulent ESKAPE pathogens30 are Gram-negative,31 we assayed E.
coli and K. pneumoniae. In addition, S. aureus 1199B overexpresses the NorA eﬄux pump and is resistant to both noroxacin and ethidium bromide.13 This Gram-positive strain was
tested with 1–4 to further evaluate NorA eﬄux pump
inhibition.32
The MICs of compounds 1–4, tetracycline, ciprooxacin, and
noroxacin were determined against tetR E. coli, K. pneumoniae
and S. aureus 1199B (Table S1†). Checkerboard experiments
were then conducted with 1–4 to assess tetracycline potency
against tetR E. coli and K. pneumoniae and noroxacin potency
against S. aureus 1199B. The concentrations of 3 and 4 ((1/4) 
(1/64) of MIC) used in the combination studies are recorded on
the abscissas of graphs in Fig. 2. Combination studies with
compounds 1 and 2 are shown in Fig. S2.† The ordinates record
the concentrations of antibiotics used, also in fractions of MIC.
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Fig. 2 Checkerboard experiments with compounds 3–4 with tetracycline against tetR E. coli (A and B); with tetracycline against K.
pneumoniae (C and D) and with norﬂoxacin against S. aureus 1199B (E
and F). Color change from blue (0% inhibition) to white (>90% inhibition) indicates increasing growth inhibition.

Bacterial growth in the presence of “hydraphile + antibiotic”
combinations is indicated by a shade of blue. Uncolored boxes
show that the potency (inhibition) of the combination was
$90%.
As seen in Fig. 2, even though the tetR E. coli and K. pneumoniae were resistant to tetracycline due to active eﬄux pumps,
hydraphiles 3–4 successfully recovered tetracycline eﬃcacy. The
extent of tetracycline recovery depended on the concentration
and the structure of hydraphile used. At 62 mM (1/4 MIC) and
125 mM (1/2 MIC) of BC8H (1), the MIC of tetracycline was
decreased from 900  50 mM to 82  15 mM and 30  8 mM,
respectively. This represents an increase in activity of tetracycline by 11-fold and 30-fold, respectively. Similarly, at 1/2 MIC of
benzyl C10, C12, and C14 hydraphiles, the activities of tetracycline in tetR E. coli were recovered by 23-, 16-, and 4-fold,
respectively. The checkerboard experiments revealed that
tetracycline activity was recovered at 8 mM of 1, 2 mM of 2,
625 nM of 3 and 500 nM of 4 against tetR E. coli.
Most of the hydraphile–tetracycline combinations tested
against tetR E. coli had fractional inhibitory concentration (FIC)
indices33 of 0.5. All of the hydraphiles showed some synergy
with tetracycline as judged by the FIC < 1 denition. Only BC8H
at 1/4 MIC (11-fold recovery) ts the narrower denition of
synergy (FIC < 0.5). Growth curves (Fig. S3†) showed that 1–4 did
not inhibit bacterial growth at #1/2 MIC. We infer that when
used in combination, inhibition occurs due to the increased
eﬃcacy of tetracycline rather than the additive eﬀect of hydraphiles and tetracycline.
We queried whether hydraphile synergy would be observed
with K. pneumoniae and S. aureus, and/or with antibiotics such
as the uoroquinolones. Against K. pneumoniae, which
possesses multiple eﬄux pumps, the activity of tetracycline was
recovered by 40-, 8-, 8-, and 16-fold at 1/2 MIC each of 1–4,
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respectively (Fig. 2c and d, S2c and d†). Benzyl C8–C14 hydraphiles also recovered ciprooxacin activity against K. pneumoniae (Table S2†). In this case, ciprooxacin resistance results
from both a point mutation and the presence of an eﬄux pump.
Similar results were observed for ciprooxacin against Grampositive bacteria. The greatest recovery of antibiotic activity
was observed against S. aureus 1199B. At 1/2 MIC of compounds
1–4, the activity of noroxacin was recovered by 128-fold against
NorA eﬄux pump expressing S. aureus 1199B (Fig. 2e and f, S2e
and f†). In the presence of 500 nM of BC14H or BC12H, the MIC
of noroxacin decreased from 64 mM to 500 nM. We speculate
that this greater potency enhancement is due to diﬀerences in
the cytosolic membranes of Gram-negative and Gram-positive
bacteria, the latter being more accessible to hydraphiles.
We next compared the activity of hydraphiles against E. coli
to that of known ionophores. At 20 mM, a peptide ion channel
(gramicidin-D), an ion carrier (valinomycin), and a detergent
(Triton X-100) showed tetracycline eﬃcacy enhancements of 1-,
2- and 2-fold, respectively, against tetR E. coli (Table S3†). Lower
concentrations showed no recovery of tetracycline activity. No
data were obtained for gramicidin-D or valinomycin, both of
which were insoluble at >20 mM.
Hydraphile activity was found to be similar to that of CCCP,
an eﬄux pump inhibitor, and to colistin, a membrane
disrupter. CCCP dissipates the proton gradient required for
antibiotic eﬄux.25 At 1/2 MIC, CCCP and colistin recovered
tetracycline activity by 4-fold and 32-fold, respectively (Table
S3†). The FIC index for CCCP was 0.75 and for colistin it was 0.5.
Toxicity limits the use of both CCCP and colistin as medicaments.34 Despite recent evidence of resistance, colistin is used
as a treatment of last resort for MDR infections. We infer that in
eﬄux pump expressing Gram-negative bacteria, membrane
disruption also enhances antimicrobial activity. As such, the
result of tetracycline recovery by BC8H is similar to that of
colistin, albeit at a much higher concentration (125 mM vs. 125
nM). The activity of eﬃcient ion transporter BC14H is similar to
that of CCCP, but hydraphiles may be functioning as membrane
disrupters as well as indirect inhibitors of eﬄux pump activity.
Two conclusions can be drawn from the checkerboard data.
First, the presence of hydraphiles 1–4 enhances antibiotic
potency irrespective of drug or organism. Second, there is
a general trend of higher potency correlated to amphiphile
chain length. The eﬃcacy of Na+ ion transport by 1–4 through
liposomal bilayers shows a similar trend.15 We infer that the
hydraphiles insert in the bacterial membranes, likely enhancing
permeability. Compounds 1–4, if of appropriate length, function as non-rectifying ion channels and alter the bacterial ion
balance. This results in a deleterious eﬀect on eﬄux pump
function. Results conrming these hypotheses are discussed
below.

Membrane localization
In order for hydraphiles to increase membrane permeability
and to form cation selective channels, they must localize in the
periphery/membrane of bacteria. Membrane localization of
hydraphiles was assessed by using a C14 hydraphile having two
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uorescent dansyl groups attached to the distal macrocycles
(Fig. S1†).4 The uorescent dansyl-terminated C14 hydraphile
was synthesized to use in tracking its localization in bacteria.
Fig. 3 shows confocal images obtained in a study of tetR E. coli
with dansyl C14 hydraphile [4 mM] and the uorescent stain
FM4-64 FX [5 mg mL1], used as a membrane-localizing control.
The uorescence intensity of the diphenylhexatrienyl dye FM464 FX increases when it passes from aqueous media into the
membrane.35
tetR E. coli cells were xed with formaldehyde aer a 5
minute treatment with FM4-64 FX followed by either a 30
second or 5 minute treatment with dansyl C14 hydraphile. Two
data sets resulting from localization studies (0.5 and 5 minute
treatments) are shown in Fig. 3. Bacteria were observed to be
healthy as judged by the bright eld image. The second column
shows that FM4-64 FX localized in the bacterial membranes
aer both 30 seconds and 5 minutes. The FM4-64 FX staining
was more visible aer 5 minutes than aer 30 seconds. Column
3 shows that dansyl C14 hydraphile (dansyl replaces benzyl in 4)
localizes in the E. coli membrane within 30 seconds. As seen in
the inserts in column 4 of Fig. 3 (30 seconds and 5 minutes),
membrane localization of dansyl C14 hydraphile was conrmed
in the overlay image of ‘hydraphile (green) + FM4-64 FX (red)’
that appears yellow in the membrane.
Three points were noted aer treating E. coli with hydraphiles. First, membrane localization is apparent in the overlay
image aer only 5 minutes. Second, the cells showed cytoplasmic localization of dansyl C14 hydraphile (Fig. 3, bottom
panel). This could result from either cell death or increased
membrane permeability; both would permit hydraphile entry
into the cytoplasm. Third, it appeared that hydraphile aggregates were present on or within the bacterial membrane. To
conrm these observations, scanning electron microscopy
(SEM) was conducted on hydraphile-treated E. coli. We also
determined if hydraphiles formed aggregates before attaching
to the bacterial surface by using SEM and dynamic light scattering (DLS). Images are shown in Fig. 4 and additional images
are shown in Fig. S4.†
As observed under SEM, the untreated E. coli showed
a corrugated surface/membrane (Fig. 4(a)). As a control,

Co-localization of FM4-64FX (5 mg mL1) and dansyl C14
hydraphile in tetR E. coli. Top panel: FM4-64FX was ﬁxed after 5
minutes and dansyl C14 hydraphile was ﬁxed after 30 seconds. Bottom
panel: FM4-64FX was ﬁxed after 5 minutes and dansyl C14 hydraphile
was ﬁxed after 5 minutes. The scale bars are 10 mm (approximately the
width of the smaller boxes).
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Fig. 4 Scanning electron microscopic images of common traits
observed with tetR E. coli when treated with BC14H (4). The image
shows the typical corrugated membrane of an untreated E. coli (a),
hydraphile aggregates on E. coli surface (b), a membrane blister on the
membrane (c), and membrane smoothening (d). The scale for all the
images is 0.5 mm (see panel d).

hydraphiles alone were observed under SEM. In aqueous media,
SEM showed that benzyl C8 and C14 hydraphiles formed
aggregates of 1–5.5 mm (Fig. S5†). When studied using DLS,
BC14H formed aggregates of 300  50 nm in dH2O. The larger
aggregates formed by hydraphiles under SEM conditions likely
reects diﬀerences in sample preparation. Notwithstanding,
aggregates were observed in both cases.
Three observations were made by using SEM concerning E.
coli treated with hydraphiles for 5 minutes. (1) Benzyl C8 and C14
hydraphile aggregates of size 226  9 nm and 164  22 nm,
respectively, were attached to the E. coli cell surface (Fig. 4(b)).
The sizes of aggregates formed in LB Miller media using DLS
were found to be 180 nm and 160 nm for BC14H at 7 mM and 3.5
mM, respectively. BC8H at 25 mM in LB Miller media formed
aggregates of 227 nm (DLS). (2) Membrane blisters and (3)
smooth outer membranes were apparent in the hydraphiletreated E. coli cells (Fig. 4(c) and (d)). Disruption of cytoplasmic membranes is known to cause leakage of cytosolic
contents into the periplasmic space, forming ‘membrane blisters’ on the surface of bacteria.36 This could account for the
membrane blisters observed in the presence of hydraphiles. The
outer membrane of E. coli is corrugated when the bacterium is
in a well-balanced ionic condition. Disruption of the internal
ion gradient may cause bacterial swelling, making the outer
membranes smooth.4 Hydraphile-mediated deregulation of the
cation gradient can cause osmotic stress leading to swelling and
smoothening of the cellular membrane. The co-localization,
DLS, and SEM studies conrm that the hydraphiles form
aggregates that attach to the E. coli surface, followed by localization in E. coli membranes. The result is membrane disruption
and osmotic stress.
The localization of dansyl C14 hydraphile was also assessed
in human embryonic kidney (HEK-293) cells (Fig. S5†), but only
at 32 mM in contrast with 4–8 mM in E. coli. Some nuclear
staining of HEK-293 cells with dansyl C14 hydraphile was also
observed. Thus, hydraphiles localize in the membranes of both
mammalian and bacterial cells, but in the former only when the
hydraphile concentration is signicantly higher. The concentration diﬀerence observed between E. coli and HEK-293 cells,
while less than 10-fold, suggests that selectivity in treatment is
possible.

Fig. 3
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Membrane permeability
The boundary membrane permeability of tetR E. coli, S. aureus
1199B, and HEK-293 cell membranes were assessed by using
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propidium iodide (PI). PI is a membrane impermeable stain. If
the permeability of the membrane increases, PI passes through
the membranes, intercalates into the nucleic acid stack and its
uorescence intensity increases. Triton X-100 and colistin were
used as controls. They both disrupt membranes, but Triton X100 is a well-known detergent whereas colistin is an antibiotic. Compounds 1–4, and controls were tested at half their
MICs.
The graph of Fig. 5(A) compares the eﬃcacy of BC14H (4), at 1
mM, 2 mM, and 4 mM. At the concentration of bacteria required
to conduct this experiment, the MIC of our most active
compound (4) was 8 mM against E. coli. Hence, 1/2 MIC of 4 for
this experiment is 4 mM against E. coli and it is 2 mM against S.
aureus. As shown in Fig. 5(A), Triton X-100 control at 0.1% (1.6
mM) increases membrane permeability in both S. aureus and E.
coli. Colistin specically targets Gram-negative bacteria; its
potency (increase in permeability) against E. coli is $2 mM. As
was the case with colistin, against E. coli, BC14H (4) increased
membrane permeability only at $1/2 MIC (4 mM). At 1 mM or 2
mM of 4, the membrane permeability of S. aureus was increased,
but that of E. coli was either unaﬀected or showed only minimal
changes. At 2 and 4 mM, compounds 1–3 showed no permeability increase for either S. aureus or E. coli (Fig. S6†). Thus,
BC14H (4) was more active than hydraphiles 1–3 against E. coli
and 4 was also more active against S. aureus than it was against
E. coli.

Fig. 5 (A) Permeability of propidium iodide to E. coli and S. aureus cell
membranes mediated by compounds 1–4, Triton X-100, and colistin.
The x-axis represents the compounds used whereas the y-axis
represents the relative ﬂuorescence unit (RFU). Error bars represent
standard deviation in three trials. (B) Benzyl C8–C14 hydraphiles (1/2
MIC) mediated permeability of propidium iodide and ﬂuorescein
diacetate in tetR E. coli (scale ¼ 10 mm) and HEK-293 (scale ¼ 100 mm).
DMSO (0.5% v/v) and Triton X-100 (0.1% v/v) were used as controls.
The top row shows bright ﬁeld images, the middle row shows FDA
ﬂuorescence and the lower row shows propidium iodide (PI)
ﬂuorescence.
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In the presence of 1/2 MIC of compounds 1–4, the membrane
permeability of S. aureus and E. coli were both increased
(Fig. S6a and b†). Likewise, at 1/2 MIC concentrations of
hydraphiles, antimicrobial potency was increased, but bacterial
growth was not inhibited in the absence of antibiotic. Evidence
was obtained by using the cell viability stain uorescein diacetate (FDA). FDA is non-uorescent until hydrolyzed by endogenous esterases and thus reports cellular vitality.37 The
uorescence of propidium iodide (PI) and FDA in hydraphiletreated E. coli and HEK-293 cells was observed by confocal
microscopy.
Fig. 5(B) shows tetR E. coli and HEK-293 cells aer treatment
with either BC14H or Triton X-100. The images shown in the
three le-hand columns of Fig. 5(B) show results for E. coli and
the three columns on the right are for HEK-293. In the E. coli
and HEK-293 cells treated with BC14H, cellular viability (FDA
panel) was comparable to that of the cells alone control. Aer
treatment with compound 4, PI penetration (PI panel) clearly
increased in E. coli, indicating enhanced membrane permeability. The increase in PI staining was comparable to that of
Triton X-100 at 0.1% (i.e. 1600 mM). Therefore, the increase in
bacterial membrane permeability, as observed in Fig. 5(A) and
(B), was not caused by cell death.
No increase in mammalian cell (HEK-293) membrane
permeability was observed at either 1/2 MIC or 2 MIC concentrations of compound 4 (Fig. 5(B)), which selectively increased
the permeability of bacterial cells. Similar results were observed
with 1/2 MIC of benzyl C8, C10, and C12 hydraphiles (Fig. S7a†).
Compounds 1–3 increased the membrane permeability of E. coli
cells without decreasing their cell viability and 1–3 did not
increase mammalian cell permeability (Fig. S7b†). We speculate
that membrane disruption and permeability increase occur at
the site of hydraphile insertion.
Benzyl C8–C14 hydraphiles (1–4) localize in both bacterial
and mammalian cell membranes, but are more disruptive of
bacterial cell membranes and enhance their permeability to
a greater extent. Some selectivity between bacterial and
mammalian cells seems likely owing to diﬀerences in their
structures. The phospholipids such as phosphatidylglycerols
found in the bacterial membranes are acidic.38 The lipopolysaccharide of Gram-negative bacteria and teichoic acids of
Gram-positive bacteria are anionic in nature.37 The cationic
property and amphiphilic nature of antimicrobial peptides such
as colistin, allow for interaction with bacterial membranes.39
Mammalian cells, on the other hand, have zwitterionic
phosphatidylcholine in the outer leaet and acidic phospholipids localized in the inner leaet of membranes.40 Mammalian
cell membranes also contain cholesterol. In previous liposomal
studies with hydraphiles, addition of cholesterol to liposomes
apparently thickened the membranes, shiing peak transport
to longer chain lengths. The sensitivity of hydraphiles to
membrane thickness suggests that some selectivity between
mammalian and bacterial membranes is possible.16 Hydraphile
penetration of bacterial membranes suggests that (1–4) could
increase membrane permeability and thus the inux of antibiotics into the cells.
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Potassium transport
Active eﬄux requires regulated cation gradients across bacterial
membranes. Hydraphiles form cation selective channels in
liposomal bilayers that transport sodium and potassium ions,
but these channels are non-rectifying. Hydraphiles will transport ions from higher to lower concentrations without regulation. To assess hydraphile-mediated cation transport in
bacteria, changes in extracellular potassium ion concentrations
were measured aer hydraphile addition to tetR E. coli. Total
potassium content of the tetR E. coli cells, determined by boiling
the bacteria at 100  C, was set to 100% and potassium cation
release is reported on that basis. No change in extracellular [K+]
was observed with 0.1% (v/v) DMSO control. The peptide ion
channel gramicidin-D [30 mM] fostered K+ eﬄux of 50–60% in
tetR E. coli (Fig. 6(A)). Compounds 1–4 were tested at 4 mM,
which is 1/2 the MIC of the most active hydraphile. In the
presence of 4 mM of benzyl C8–C14 hydraphiles, 6% (1), 4% (2),
21% (3), and 40% (4) of K+ release was observed (Fig. 6(A)). The
potassium release prole 4 > 3 > 2 z 1 correlates directly with
the potency enhancement of tetracycline against tetR E. coli
(Fig. S8a†).
Loss of internal K+ ion is known to occur when bacterial
membrane integrity is compromised. We determined potassium release from E. coli as a function of increasing hydraphile
concentration. As seen in Fig. 6(B), increase in the concentration of 4, increases the potassium release from E. coli. The K+
release from E. coli also increased with increasing concentration
of 1–3 (Fig. S8b–e†).
The gramicidin-D control showed K+ release to the extent of
50–60% (Fig. 6(A)) when administered at 30 mM. Potassium
release by BC14H (4) at 4 mM was 40%. When the concentration of 4 was increased from 4 mM to 6 mM, 8 mM, and 10 mM, K+
ion release was enhanced (Fig. 6(B)). Indeed the gramicidin-D

(A) Potassium ion release from E. coli cells 10 minutes after
treatment with DMSO, gramicidin-D (control) and benzyl C8–C14
hydraphiles (compounds 1–4). The total potassium pool of E. coli was
determined by boiling the bacteria at 100  C for 30 minutes. (B)
Change in extracellular potassium concentration over 12 minutes of
treatment with various concentrations of benzyl C14 hydraphile (4).
Error bars represent standard deviation in three trials.
Fig. 6
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release level at 30 mM was exceeded at 6 mM of 4. When the
concentration of 4 reached 10 mM, more than 80% of the
bacterial pool was released (Fig. 6(B)). No inhibition of E. coli
growth was apparent at 1/2 MIC of compound 4. This indicates
that at lower concentrations the cation release could be due to
the ability of hydraphiles to form channels rather than as
a result of membrane disruption or cell death. Membrane
penetration and ion transport by hydraphiles is well established, but these two potential contributors have not yet been
clearly distinguished. Both processes seem likely as is known
for such peptide amphiphiles as colistin and daptomycin.41
Among the compounds tested, the best ion transporters in
liposomes15 also showed the highest level of K+ release in E.
coli—an interesting parallel considering how diﬀerent are the
boundary membranes.

Eﬄux pump inhibition
The combination of increased membrane permeability and
disruption of cation gradients results in eﬄux pump inhibition.
Eﬄux pump activity was assayed by evaluating changes in
cytoplasmic concentrations of an eﬄux pump substrate. S.
aureus (1199B) over-expresses the NorA eﬄux pump, for which
ethidium bromide (EthBr) and noroxacin are substrates.30 To
the extent EthBr enters the cell cytoplasm, it intercalates with
DNA, forming a complex in which uorescence intensity is
dramatically enhanced. Combination studies were rst conducted to conrm that activity of either EthBr or noroxacin
could be recovered by compounds 1–4. The benzyl C8–C14
hydraphiles at 1/2 MIC increased the eﬃcacy of EthBr against S.
aureus by 2-, 26-, 8-, and 32-fold, respectively (Table S4†). Note
that noroxacin activity against S. aureus 1199B was also
recovered by 1–4 as shown above in Fig. 2.
Two studies were conducted to determine the eﬀect of
hydraphiles on bacteria expressing NorA eﬄux pumps. We rst
determined the ability of the bacterial NorA eﬄux pump to
export EthBr in the presence or absence of hydraphiles
(Fig. 7(A)). Thus, S. aureus 1199B cells were preloaded with
EthBr by treating S. aureus 1199B with CCCP [100 mM], a known
eﬄux pump inhibitor. Extracellular EthBr and CCCP were
removed by washing the cells, followed by addition of 4 mM of 1,
2, 3, or 4. The MIC of BC14H (4) is 8 mM against S. aureus (at
OD600 0.800), i.e. [4 mM] ¼ 1/2 MIC. The graph of Fig. 7(A)
compares the eﬀect on S. aureus 1199B of hydraphiles and
known eﬄux pump inhibitors. EthBr's uorescent intensity
decreased similarly with untreated and 0.5% aq. DMSO-treated
S. aureus (Fig. 7(A)). The EthBr uorescence was little aﬀected by
the presence of 4 mM benzyl C10, C12, or C14 hydraphile. Eﬄux
pump function was found to be inhibited to a similar extent by
BC14H (4) at 4 mM, CCCP at 100 mM, and reserpine at 41 mM.
When the concentrations of CCCP and reserpine were
decreased to 4 mM, to match that of BC14H, inhibition of NorA
activity was 30% lower than for 3 or 4. Benzyl C8 hydraphile at
4 mM showed minimal/no NorA eﬄux pump inhibition in S.
aureus.
A complementary experiment was conducted by observing
cytoplasmic EthBr accumulation in S. aureus 1199B in the
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Cytotoxicity and resistance development

Fig. 7 Hydraphiles inhibit the activity of eﬄux pumps. (A) Release of
ethidium bromide from S. aureus 1199B after treatment with reserpine,
CCCP, benzyl C8–C14 hydraphiles [4 mM]. The abscissa reports time in
minutes and the ordinate reports fractional ﬂuorescence. (B) Accumulation of ethidium bromide in the presence of reserpine, CCCP,
benzyl C8–C14 hydraphiles (4 mM) in S. aureus 1199B. The abscissa
records time in minutes and the ordinate records normalized ﬂuorescence. The error bars represent the standard deviation in three
independent trials.

presence of hydraphiles (Fig. 7(B)). EthBr was added to S. aureus
1199B cells followed by one of 1–4 or a control. Changes in
uorescence were monitored during 20 min. The graph of
Fig. 7(B) shows that EthBr accumulation was observed following
addition of benzyl C12 and C14 hydraphiles, but not the C8 and
C10 analogs. Note that the eﬀect of BC12H at 4 mM was similar to
that of CCCP at 100 mM and reserpine at 41 mM (¼25 mg mL1).
Benzyl C8 and C10 hydraphiles proved ineﬀective at 4 mM; higher
concentrations of these compounds were not tested.
The data obtained with S. aureus 1199B show that hydraphiles inhibit eﬄux pump activity, causing antibiotics to accumulate in the bacterial cell cytoplasm. Benzyl C12 and C14
hydraphiles are at least comparable to and better, in some
cases, than standard eﬄux pump inhibitors such as CCCP and
reserpine. The hydraphiles could mediate both the accumulation of EthBr and inhibition of NorA eﬄux pump either by
disruption of membrane integrity or uncoupling of the eﬄux
pump from the ion gradient, or both.
The data obtained thus far conrm that hydraphiles localize
in the membranes of both bacterial and mammalian cells. They
aﬀect the membrane permeability of bacterial cells, but they
show little eﬀect on mammalian cells. Their presence in
bacterial membranes results in potassium eﬄux from the
microbe's cytosol. Hydraphiles also inhibit eﬄux pump activity
and allow for substrate accumulation in the bacterial cytoplasm. As a result, even at #1/2 MIC of hydraphiles, the activity
of antibiotics were recovered against MDR bacteria. Concerns
over mammalian cytotoxicity and resistance development by E.
coli to hydraphiles are obviously key questions and are
addressed below.
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The clinical use of both colistin and CCCP is limited due to
cytotoxicity.42 Renal toxicity is a common issue with amphiphilic molecules.34 For a hydraphile to be an eﬀective antibiotic
adjuvant, its cytotoxicity to mammalian cells should be low. The
cytotoxicity was evaluated for benzyl C8–C14 hydraphiles against
two mammalian epithelial cell lines: human embryonic kidney
(HEK-293), and simian kidney (Cos-7). Colistin and CCCP
served as controls. The viability of the cell lines in the presence
of 1/2 MIC of benzyl C8–C14 hydraphiles (1–4), colistin, and
CCCP are recorded in Fig. 8(A) below.
CCCP was cytotoxic to all three cell lines. Colistin at 1/2 MIC
(0.125 mM) was non-cytotoxic to Cos-7, but HEK-293 showed
only about 60% survival. Similar to colistin, compounds 1–4
were completely non-cytotoxic (100% survival) to Cos-7 cell line
at 1/2 MIC. Even at MIC concentrations of compounds 1–4, that
are twice the concentrations required for adjuvant activity, the
survival of Cos-7 was 100% (data not shown). The survival of
HEK in the presence of 1/2 MIC of 4 (1 mM) was 70–80%. Hence,

Fig. 8 Cytotoxicity and resistance development to benzyl hydraphiles.
(A) Cytotoxicity of benzyl C8–C14 hydraphiles and colistin and CCCP at
1/2 MIC concentrations against HEK-293, and Cos-7 cells. The
abscissa represents the compounds used and the ordinate represents
the percent of cells that survived in the presence of the respective
compounds. The error bars represent the standard deviation for three
trials. (B) Resistance development by tetR E. coli to BC14H (circles) and
minocycline (triangles). The x-axis represents time in days and the yaxis represents increase in MIC (in folds). The data represents the
average of three diﬀerent trials.
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the cytotoxicity of BC14H (4) at 1 mM, is lower than that of
colistin at 0.125 mM. The survival of HEK-293 cells in the presence of 1/2 MIC of 1, 2, or 3 was 50–70%, comparable to the
cytotoxicity of colistin (60%).
We determined the median eﬀective concentration (EC50) of
compound 4 against human hepatocytes (Fig. S9†). CCCP was
used as a control. Survival of human hepatocytes was determined aer treating them with 1–100 mM of either compound 4
or CCCP for 72 hours. The EC50 for CCCP was found to be 5 mM.
The EC50 for BC14H was 2.1 mM. At 1 mM, 80–100% cell viability
was observed for 4. Thus, 4, at concentrations of 500 nM to 1
mM, is non-cytotoxic to HEK-293, Cos-7, and human hepatocytes. At 1 mM 4 recovers antibiotic activity in MDR bacteria
(Fig. 2), while being less cytotoxic than colistin. Analogs of 1–4
that show lower cytotoxicity might be required for clinical use.
Additional analogs that show better solubility and lower cytotoxicity are under study.
A major concern with any antibiotic is bacterial resistance.
Newer antibiotics are oen limited in use to conserve their
potency. Compounds that target membranes are usually less
prone to resistance development by bacteria than those acting
exclusively in the cytosol. For example, polymyxins (colistin)
have been in clinical use for >50 years, but resistance to polymyxin was identied only recently.12 It is known that developing
resistance to a membrane active compound would require
multiple changes in membrane composition/synthesis pathways and is energetically unfavorable.2 The data reported here
show that hydraphiles are membrane targeting molecules. We
therefore exposed tetR E. coli to 4 and to minocycline (positive
control) by using the sequential culturing method. E. coli were
treated with increasing fractional MIC concentrations of
compound 4, for 15 days. The highest concentration of the
compound that showed growth was used to determine MICs.
Fig. 8(B) shows that tetR E. coli readily developed 40-fold resistance to minocycline (12–15 days). Resistance to 4 did not
exceed 1.5- to 2-fold during 15 days. Taken together, at its active
concentration, 4 was less cytotoxic than colistin and not
susceptible to resistance development in E. coli.

Conclusions
We present the results of a study showing the potential of
synthetic ionophores—hydraphiles—as medicaments and as
adjuvants. Hydraphiles and other synthetic ionophores have
been known for decades. Most of the studies involving such
molecules have focused on developing new structures,6
measuring their binding proles, assessing their eﬀect on ion
transport,5 and simple surveys of antibacterial or antifungal
properties.26 This is the rst report of a synthetic amphiphile
that can be used to recover the eﬃcacy of antibiotics against
eﬄux pump expressing multidrug resistant bacteria or ‘superbugs’. The hydraphiles recovered the activity of tetracycline and
uoroquinolones (ciprooxacin, noroxacin) against two Gramnegative and one Gram-positive bacteria. Ciprooxacin and
tetracycline activity were recovered by hydraphiles against MDR
K. pneumoniae. This demonstrates that hydraphiles can be used
to recover antimicrobial potency against MDR bacteria even
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when resistance arises from multiple resistance mechanisms.
BC14H was most eﬀective as an adjuvant against multiple
diﬀerent bacterial strains. Controls indicated that the activity of
our synthetic ionophores is similar to that of the eﬄux pump
inhibitor CCCP and to a membrane disrupting peptide such as
colistin.
At sub-lethal concentrations, our synthetic ionophores
resensitize resistant bacteria, likely by a combination of
enhanced membrane permeability and by interrupting ion
gradients required for eﬄux pump function. Studies revealed
that hydraphiles form aggregates that attach to the bacterial
surface followed by localizing in the cellular membrane.
Hydraphiles then selectively increase membrane permeability
in bacteria. Eﬄux pump activity was observed to be inhibited,
presumably due to uncoupling of the cation gradient. As
a result, more antibiotics pass through the membranes and
accumulate in the cytosol. Such function recovers or increases
the potency of existing antibiotics. We determined that among
the compounds tested, BC14H was the most eﬃcient amphiphile at recovering antimicrobial potency, increasing
membrane permeability, cation transport and inhibiting eﬄux
pump activity. BC14H showed greater activity against Grampositive bacteria, had the lowest mammalian cell cytotoxicity,
and E. coli failed to develop resistance against it. Taken
together, these novel synthetic amphiphiles hold forth potential
as antibiotics per se and as adjuvants to enhance antimicrobial
potency and to resensitize resistant pathogens.
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